ArticleHaematologica2021

Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trial.

Matthieu Mahévas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.